Athersys
ATHX
#10714
Rank
NZ$1.41 M
Marketcap
NZ$0.02288
Share price
-33.50%
Change (1 day)
-98.89%
Change (1 year)

Earnings for Athersys (ATHX)

Earnings in 2023 (TTM): -NZ$67.38 Million

According to Athersys's latest financial reports the company's current earnings are NZ$0.08 Million. In 2022 the company made an earning of -NZ$0.14 Billion, an increase over its 2021 earnings that were of -NZ$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Athersys from 2007 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -NZ$67.38 Million-48.37%
2022 -NZ$0.14 Billion-11.54%
2021 -NZ$0.15 Billion11.14%
2020 -NZ$0.14 Billion72.2%
2019 -NZ$77.1 Million77.29%
2018 -NZ$43.49 Million-22.91%
2017 -NZ$56.41 Million111.89%
2016 -NZ$26.63 Million-8.52%
2015 -NZ$29.11 Million-40.81%
2014 -NZ$49.17 Million18.62%
2013 -NZ$41.45 Million
2011 -NZ$23.36 Million19.71%
2010 -NZ$19.51 Million-26.28%
2009 -NZ$26.47 Million-18.21%
2008 -NZ$32.36 Million-8.28%
2007 -NZ$35.28 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$56.86 B-80,440.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$17.27 B-24,504.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.21 B-21,593.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$13.04 B-18,536.14%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$38.00 B-53,792.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$15.80 B-22,436.10%๐Ÿ‡บ๐Ÿ‡ธ USA
United States Lime & Minerals
USLM
NZ$0.28 B-509.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-NZ$4.68 Billion 6,504.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-NZ$1.07 Billion 1,401.18%๐Ÿ‡บ๐Ÿ‡ธ USA